spacer
home > pmps > spring 2017 > easy access
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Easy Access

Times have changed dramatically in the past 10 years, with external cost pressure, patent losses, dried-up R&D pipelines and the rise of biosimilars forcing Big Pharma to rethink its business models. All of a sudden, the cost of packaging drugs can make a telling difference to the bottom line, or even mean the difference between winning a tender or not.

All of this comes in an environment where patients are hoping for greater protection from external contamination, counterfeits and their children accessing dangerous drugs, and payers are expecting the industry to demonstrate the effectiveness of their products. But how can pharmaceutical companies balance the conflicting needs of lower cost and higher protection?

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Colin Reed is Marketing and Strategy Director for Amcor Flexibles Global Pharma and Medical EMEA businesses. He has 19 years of experience in pharmaceutical packaging and has held previous leadership positions in operations and marketing, including managing businesses in the Asia- Pacific region. Colin holds a Bachelor of Engineering degree and an MBA from Aston University, UK.

Greg Rosati is currently the Healthcare Marketing Director for Amcor Rigid Plastics. He has 24 years of packaging experience including 15 in healthcare and has held various leadership roles in product development, sales, marketing and quality systems. Greg holds a BS from Michigan State University, US.
spacer
Colin Reed
spacer
spacer
spacer
Greg Rosati
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

BBI Solutions broadens antibody portfolio and strengthens reagent technical support capabilities with acquisition of Maine Biotechnology Services

BBI, a leading manufacturer of raw materials and finished test platforms, already provides human antigens, antibodies, serum and plasma products and clinical chemistry enzymes, for the in-vitro diagnostics market. Now with the acquisition of MBS they have strengthened their antibody offering, providing a comprehensive portfolio and custom services to deliver a total reagent solution for any immunoassay development.
More info >>

White Papers

What You Need To Know About Thermal Shipping Technologies

Temptime Corporation

This paper presents highlights from a thermal performance study conducted by Modality Solutions LLC. The study examined the performance of five shipping technologies commonly used by specialty pharmacies to transport high-value refrigerated specialty medicines against an industry accepted temperature profile standard.
More info >>

 
Industry Events

12th Annual Paediatric Clinical Trials

19-20 March 2018, Copthorne Tara Hotel, London, UK

SMi is pleased to present the return of their 12th annual Paediatric Clinical Trials Conference taking place on 19th 20th March 2018, London, UK.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement